• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BECTON DICKINSON, S.A. BD PHASEAL OPTIMA INJECTOR (N35-O); INTRAVASCULAR ADMINISTRATION SET

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BECTON DICKINSON, S.A. BD PHASEAL OPTIMA INJECTOR (N35-O); INTRAVASCULAR ADMINISTRATION SET Back to Search Results
Catalog Number 515052
Device Problem Difficult or Delayed Activation (2577)
Patient Problem No Clinical Signs, Symptoms or Conditions (4582)
Event Date 07/29/2021
Event Type  malfunction  
Manufacturer Narrative
A device evaluation is anticipated but has not yet begun.Upon completion of the investigation, a supplemental report will be filed.
 
Event Description
It was reported that the needle became exposed when the outer membrane of the bd phaseal¿ optima injector (n35-o) stuck to the protector during disengagement.The following information was provided by the initial reporter: "while compounding a hazardous drug, the membrane and outer layer of the optima injector (n35-o) stuck to the vial protector and exposed the needle.".
 
Manufacturer Narrative
H.6.Investigation: one photo received for investigation, one optima injector hub connected to a syringe with the needle exposed was observed.Fifteen retained samples from the same lot were used for additional evaluation.No damage or other defects was observed on any of the product.Functional testing was performed, connecting the injector to a sample syringe, protector and vial according to the instructions for use.Each sample was tested ten times and each time there were no issues observed with the syringes and the injector.Issue observed by the customer (luer lock breakage) could not be replicated on none of retained samples and therefore the event reported could not be confirmed.Moreover, a short-term leakage test was performed on injector for 30 samples, no issues were found that could be involved in the incidence reported.No luer lock breakage nor broken injector safety sleeve was noticed.In all cases, the product functioned properly and there were no issues observed between the connection of the injectors and protector.Product undergoes inspections throughout the manufacturing process to ensure the quality and functionality of the device, including verification all critical dimensions are within specification and there is no damage on the product.A device history review was performed for the reported lot 2101309, no deviations or non-conformances were identified during the manufacturing process that could have contributed to this issue.Testing results were reviewed for the reported lot and found all product met required specifications.Based on the quality team's investigation, we are not able to identify a root cause related to our manufacturing process at this time.H3 other text : see h.10.
 
Event Description
It was reported that the needle became exposed when the outer membrane of the bd phaseal¿ optima injector (n35-o) stuck to the protector during disengagement.The following information was provided by the initial reporter: "while compounding a hazardous drug, the membrane and outer layer of the optima injector (n35-o) stuck to the vial protector and exposed the needle.".
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
BD PHASEAL OPTIMA INJECTOR (N35-O)
Type of Device
INTRAVASCULAR ADMINISTRATION SET
Manufacturer (Section D)
BECTON DICKINSON, S.A.
camino de valdeolivia
s/n
san agustin de guadalix
MDR Report Key12407189
MDR Text Key269408583
Report Number3003152976-2021-00536
Device Sequence Number1
Product Code ONB
Combination Product (y/n)N
PMA/PMN Number
K181221
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type other,user facility
Type of Report Initial,Followup
Report Date 09/21/2021
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Other
Device Expiration Date03/31/2022
Device Catalogue Number515052
Device Lot Number2101309
Was Device Available for Evaluation? No
Initial Date Manufacturer Received 08/03/2021
Initial Date FDA Received09/01/2021
Supplement Dates Manufacturer Received09/21/2021
Supplement Dates FDA Received10/14/2021
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
-
-